Prognostic implications of tumour marker analysis in non-seminomatous germ cell tumours with poor prognosis metastatic disease

This publication has 16 references indexed in Scilit:

• Serum lactate dehydrogenase isoenzyme 1 and tumour volume are indicators of response to treatment and predictors of prognosis in metastatic testicular germ cell tumours
  European Journal Of Cancer, 1992
• Combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for metastatic testicular teratoma: Long-term follow-up
  European Journal of Cancer and Clinical Oncology, 1991
• Treatment of testicular cancer: a new and improved model.
  Journal of Clinical Oncology, 1990
• The growth rate of metastatic non-seminomatous germ cell testicular tumours measured by marker production doubling time— I. Theoretical basis and practical application
  European Journal of Cancer and Clinical Oncology, 1990
• Vierfach-Kombination beim nichtseminomatösen Hodentumor mit ungünstiger Prognose
  Published by Springer Nature ,1988
• Cyclic chemotherapy with cyclophosphamide, doxorubicin, and cisplatin plus vinblastine and bleomycin in advanced germinal tumors. Results with 100 patients
  The American Journal of Medicine, 1986
• Lactate dehydrogenase as a marker for testicular germ-cell tumours
  European Journal of Cancer and Clinical Oncology, 1986
• Münchner Nachsorge-Schema bei fortgeschrittenen nicht-seminomatösen Hodentumoren: Nutzen und Kosten
  Deutsche Medizinische Wochenschrift (1946), 1986
• Alpha-Fetoprotein: Methodik und klinische Erfahrungen mit einem neuen Radioimmunoassay
  Analytical and Bioanalytical Chemistry, 1976
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958